{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T10:23:19Z","timestamp":1780568599610,"version":"3.54.1"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.thromres.2024.109203","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T08:11:58Z","timestamp":1730707918000},"page":"109203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Increased risk of pulmonary embolism in patients with dermatomyositis\/polymyositis, a retrospective cohort study from Israel"],"prefix":"10.1016","volume":"244","author":[{"given":"Roi","family":"Amster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulla","family":"Watad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uria","family":"Shani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis","family":"McGonagle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon D.","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard","family":"Amital","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niv","family":"Ben-Shabat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.thromres.2024.109203_bb0005","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/mus.23302","article-title":"Epidemiology of adult idiopathic inflammatory myopathies in a U.S. managed care plan","volume":"45","author":"Furst","year":"2012","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.thromres.2024.109203_bb0010","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/ard.2008.093161","article-title":"Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences","volume":"68","author":"Bernatsky","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.thromres.2024.109203_bb0015","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2474-13-103","article-title":"Incidence and prevalence of idiopathic inflammatory myopathies among commercially insured, Medicare supplemental insured, and Medicaid enrolled populations: an administrative claims analysis","volume":"13","author":"Smoyer-Tomic","year":"2012","journal-title":"BMC Musculoskelet. Disord."},{"issue":"5","key":"10.1016\/j.thromres.2024.109203_bb0020","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/mus.24566","article-title":"An overview of polymyositis and dermatomyositis","volume":"51","author":"Findlay","year":"2015","journal-title":"Muscle Nerve"},{"issue":"7","key":"10.1016\/j.thromres.2024.109203_bb0025","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/ard.2008.093161","article-title":"Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences","volume":"68","author":"Bernatsky","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"3","key":"10.1016\/j.thromres.2024.109203_bb0030","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s11926-010-0100-7","article-title":"Cutaneous manifestations of dermatomyositis and their management","volume":"12","author":"Callen","year":"2010","journal-title":"Curr. Rheumatol. Rep."},{"issue":"Suppl. 1","key":"10.1016\/j.thromres.2024.109203_bb0035","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1186\/ar2885","article-title":"Type 1 interferons and myositis","volume":"12","author":"Greenberg","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.thromres.2024.109203_bb0040","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/rheumatology\/kez248","article-title":"A new in vitro model of polymyositis reveals CD8+ T cell invasion into muscle cells and its cytotoxic role","volume":"59","author":"Kamiya","year":"2020","journal-title":"Rheumatology"},{"issue":"2","key":"10.1016\/j.thromres.2024.109203_bb0045","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosissup.2005.02.005","article-title":"Markers of inflammation and their clinical significance","volume":"6","author":"Ballantyne","year":"2005","journal-title":"Atheroscler. Suppl."},{"key":"10.1016\/j.thromres.2024.109203_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtauto.2019.100018","article-title":"Polymyositis and dermatomyositis \u2013 challenges in diagnosis and management","volume":"2","author":"Yang","year":"2019","journal-title":"J Transl Autoimmun."},{"issue":"12","key":"10.1016\/j.thromres.2024.109203_bb0055","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1136\/annrheumdis-2017-211468","article-title":"2017 European League Against Rheumatism\/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups","volume":"76","author":"Lundberg","year":"2017","journal-title":"Ann. Rheum. Dis."},{"issue":"10","key":"10.1016\/j.thromres.2024.109203_bb0060","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1056\/NEJMra072753","article-title":"Acute pulmonary embolism","volume":"358","author":"Tapson","year":"2008","journal-title":"N. Engl. J. Med."},{"issue":"9162","key":"10.1016\/j.thromres.2024.109203_bb0065","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S0140-6736(98)07534-5","article-title":"Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER)","volume":"353","author":"Goldhaber","year":"1999","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.thromres.2024.109203_bb0070","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1055\/s-0037-1613858","article-title":"Recurrent venous thrombosis and markers of inflammation","volume":"83","author":"van Aken","year":"2000","journal-title":"Thromb. Haemost."},{"issue":"5","key":"10.1016\/j.thromres.2024.109203_bb0075","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.blre.2009.07.002","article-title":"Basic mechanisms and pathogenesis of venous thrombosis","volume":"23","author":"Esmon","year":"2009","journal-title":"Blood Rev."},{"issue":"1","key":"10.1016\/j.thromres.2024.109203_bb0080","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2310\/JIM.0b013e31820017f2","article-title":"C-reactive protein in acute pulmonary embolism","volume":"59","author":"Abul","year":"2011","journal-title":"J. Investig. Med."},{"issue":"9","key":"10.1016\/j.thromres.2024.109203_bb0085","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1553-2712.2008.00203.x","article-title":"Direct comparison of the diagnostic accuracy of fifty protein biological markers of pulmonary embolism for use in the emergency department","volume":"15","author":"Nordenholz","year":"2008","journal-title":"Acad. Emerg. Med."},{"issue":"7","key":"10.1016\/j.thromres.2024.109203_bb0090","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s00296-017-3735-0","article-title":"Idiopathic inflammatory myopathy and the risk of venous thromboembolism: a meta-analysis","volume":"37","author":"Lee","year":"2017","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.thromres.2024.109203_bb0095","doi-asserted-by":"crossref","first-page":"157","DOI":"10.2147\/TCRM.S157085","article-title":"Increased risk of venous thromboembolism associated with polymyositis and dermatomyositis: a meta-analysis","volume":"14","author":"Li","year":"2018","journal-title":"Ther. Clin. Risk Manag."},{"issue":"11","key":"10.1016\/j.thromres.2024.109203_bb0100","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1111\/j.1538-7836.2010.04044.x","article-title":"A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score","volume":"8","author":"Barbar","year":"2010","journal-title":"J. Thromb. Haemost."},{"issue":"1","key":"10.1016\/j.thromres.2024.109203_bb0105","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1378\/chest.09-3081","article-title":"Factors at admission associated with bleeding risk in medical patients","volume":"139","author":"Decousus","year":"2011","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.thromres.2024.109203_bb0110","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/0003-4819-146-4-200702200-00007","article-title":"Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients","volume":"146","author":"Dentali","year":"2007","journal-title":"Ann. Intern. Med."},{"issue":"9","key":"10.1016\/j.thromres.2024.109203_bb0115","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3899\/jrheum.190927","article-title":"Mortality among patients with giant cell arteritis: a large-scale population-based cohort study","volume":"47","author":"Ben-Shabat","year":"2020","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.thromres.2024.109203_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13075-017-1497-4","article-title":"The epidemiology of psoriatic arthritis in Israel \u2013 a population-based study","volume":"20","author":"Eder","year":"2018","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.thromres.2024.109203_bb0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1136\/annrheumdis-2013-205148","article-title":"Psoriatic arthritis treatment and the risk of herpes zoster","volume":"75","author":"Zisman","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.thromres.2024.109203_bb0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijcard.2017.02.135","article-title":"Investigating the link between ischemic heart disease and Behcet\u2019s disease: a cross-sectional analysis","volume":"241","author":"Yavne","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"6","key":"10.1016\/j.thromres.2024.109203_bb0135","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2019.1588084","article-title":"Autoantibody status in systemic sclerosis patients defines both cancer risk and survival with ANA negativity in cases with concomitant cancer having a worse survival","volume":"8","author":"Watad","year":"2019","journal-title":"Oncoimmunology"},{"issue":"5","key":"10.1016\/j.thromres.2024.109203_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051400","article-title":"Low vitamin D levels predict mortality in ankylosing spondylitis patients: a nationwide population-based cohort study","volume":"12","author":"Ben-Shabat","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/j.thromres.2024.109203_bb0145","doi-asserted-by":"crossref","unstructured":"Ramagopalan S v, Wotton CJ, Handel AE, Yeates D, Goldacre MJ. Risk of venous thromboembolism in people admitted to hospital with selected immune-mediated diseases: record-linkage study. BMC Med. 2011;9(1):1. doi:https:\/\/doi.org\/10.1186\/1741-7015-9-1.","DOI":"10.1186\/1741-7015-9-1"},{"issue":"9812","key":"10.1016\/j.thromres.2024.109203_bb0150","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/S0140-6736(11)61306-8","article-title":"Risk of pulmonary embolism in patients with autoimmune disorders: a nationwide follow-up study from Sweden","volume":"379","author":"Z\u00f6ller","year":"2012","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.thromres.2024.109203_bb0155","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.thromres.2014.06.021","article-title":"Increased risk of venous thromboembolism in patients with dermatomyositis\/polymyositis: a nationwide cohort study","volume":"134","author":"Chung","year":"2014","journal-title":"Thromb. Res."},{"issue":"1","key":"10.1016\/j.thromres.2024.109203_bb0160","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1136\/annrheumdis-2014-205800","article-title":"Risk of deep venous thrombosis and pulmonary embolism in individuals with polymyositis and dermatomyositis: a general population-based study","volume":"75","author":"Carruthers","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"5","key":"10.1016\/j.thromres.2024.109203_bb0165","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1538-7836.2012.04666.x","article-title":"Autoimmune skin and connective tissue diseases and risk of venous thromboembolism: a population-based case-control study","volume":"10","author":"Johannesdottir","year":"2012","journal-title":"J. Thromb. Haemost."},{"issue":"3","key":"10.1016\/j.thromres.2024.109203_bb0170","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1177\/1076029614553023","article-title":"Risk of venous thromboembolic events in pregnant patients with autoimmune diseases","volume":"22","author":"Bleau","year":"2016","journal-title":"Clin. Appl. Thromb. Hemost."},{"issue":"12","key":"10.1016\/j.thromres.2024.109203_bb0175","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/acr.23560","article-title":"Venous thromboembolic events in idiopathic inflammatory myopathy: occurrence and relation to disease onset","volume":"70","author":"Antovic","year":"2018","journal-title":"Arthritis Care Res."},{"issue":"1","key":"10.1016\/j.thromres.2024.109203_bb0180","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/s41598-018-38108-y","article-title":"Elevated plasma D-dimer levels in dermatomyositis patients with cutaneous manifestations","volume":"9","author":"Habe","year":"2019","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.thromres.2024.109203_bb0185","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/096120339700600510","article-title":"Risk for venous thrombosis related to antiphospholipid antibodies in systemic lupus erythematosus\u2014a meta-analysis","volume":"6","author":"Wahl","year":"1997","journal-title":"Lupus"},{"issue":"2","key":"10.1016\/j.thromres.2024.109203_bb0190","doi-asserted-by":"crossref","first-page":"75","DOI":"10.5152\/eurjrheum.2015.0085","article-title":"The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus","volume":"3","author":"Unlu","year":"2016","journal-title":"Eur J Rheumatol."},{"issue":"2","key":"10.1016\/j.thromres.2024.109203_bb0195","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s11926-006-0049-8","article-title":"The prevalence and clinical significance of antiphospholipid antibodies in rheumatoid arthritis","volume":"8","author":"Olech","year":"2006","journal-title":"Curr. Rheumatol. Rep."},{"issue":"1","key":"10.1016\/j.thromres.2024.109203_bb0200","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s42358-021-00171-x","article-title":"The relevance of anti-Jo-1 autoantibodies in patients with definite dermatomyositis","volume":"61","author":"de Andrade","year":"2021","journal-title":"Advances in Rheumatology."},{"issue":"9","key":"10.1016\/j.thromres.2024.109203_bb0205","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.autrev.2014.03.004","article-title":"The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome","volume":"13","author":"Lega","year":"2014","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.thromres.2024.109203_bb0210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2019.04.001","article-title":"Frequency, mutual exclusivity and clinical associations of myositis autoantibodies in a combined European cohort of idiopathic inflammatory myopathy patients","volume":"101","author":"Betteridge","year":"2019","journal-title":"J. Autoimmun."},{"issue":"6","key":"10.1016\/j.thromres.2024.109203_bb0215","doi-asserted-by":"crossref","first-page":"827","DOI":"10.17219\/acem\/78361","article-title":"High prevalence of antinuclear antibodies in patients following venous thromboembolism","volume":"27","author":"Natorska","year":"2018","journal-title":"Adv. Clin. Exp. Med."},{"issue":"1","key":"10.1016\/j.thromres.2024.109203_bb0220","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1055\/s-0037-1617146","article-title":"Inflammation, innate immunity and blood coagulation","volume":"30","author":"Xu","year":"2010","journal-title":"Hamostaseologie"},{"issue":"2","key":"10.1016\/j.thromres.2024.109203_bb0225","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1378\/chest.05-2799","article-title":"The natural course of hemodynamically stable pulmonary embolism","volume":"131","author":"Nijkeuter","year":"2007","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.thromres.2024.109203_bb0230","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1182\/blood.V82.2.513.513","article-title":"C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor","volume":"82","author":"Cermak","year":"1993","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.thromres.2024.109203_bb0235","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1111\/j.1538-7836.2007.02645.x","article-title":"Immobilization resulting from chronic medical diseases: a new risk factor for recurrent venous thromboembolism in anticoagulated patients","volume":"5","author":"Prandoni","year":"2007","journal-title":"J. Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824003359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824003359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,19]],"date-time":"2025-01-19T14:42:52Z","timestamp":1737297772000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824003359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":47,"alternative-id":["S0049384824003359"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109203","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased risk of pulmonary embolism in patients with dermatomyositis\/polymyositis, a retrospective cohort study from Israel","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109203"}}